Get started
Author

Nicholas I. Wreglesworth

Observed names: N. Wreglesworth, Nicholas I Wreglesworth
ORCID: 0009-0001-3598-0905
Observed ORCID: 0009-0001-3598-0905
OpenAlex ID: A5035670730
Why does circadian timing of administration matter for immune checkpoint inhibitors’ efficacy?
2024 · Abdoulaye Karaboué, Pasquale F. Innominato, et al. · British Journal of Cancer · 122
Circadian rest‐activity rhythm as an objective biomarker of patient‐reported outcomes in patients with advanced cancer
2018 · Pasquale F. Innominato, Sandra Komarzynski, et al. · Cancer Medicine · 71
PDF
The day after: correlates of patient-reported outcomes with actigraphy-assessed sleep in cancer patients at home (inCASA project)
2019 · Sandra Komarzynski, Qi Huang, et al. · SLEEP · 24
PDF
Impact of assessment frequency of patient-reported outcomes: an observational study using an eHealth platform in cancer patients
2021 · Pasquale F. Innominato, Sandra Komarzynski, et al. · Supportive Care in Cancer · 21
Circadian lifestyle determinants of immune checkpoint inhibitor efficacy
2023 · Bethan R. Hughes, Sadiq Shanaz, et al. · Frontiers in Oncology · 14
PDF
Personalizing chronotherapy of immune checkpoint blockade
2025 · Seline Ismail-Sutton, Bethan Hughes, et al. · Journal for ImmunoTherapy of Cancer · 9
PDF
Rest–activity rhythm as a clinical biomarker in cancer
2023 · Pasquale F Innominato, Nicholas I Wreglesworth, et al. · The Lancet Healthy Longevity · 9
PDF
Embracing Change: Learnings From Implementing Multidimensional Digital Remote Monitoring in Oncology Patients at a District General Hospital During the COVID-19 Pandemic
2021 · Sandra Komarzynski, Nicholas I. Wreglesworth, et al. · JCO Clinical Cancer Informatics · 6
Holistic Needs Assessment of Cancer Survivors—Supporting the Process Through Digital Monitoring of Circadian Physiology
2022 · Max Gibb, Hannah Winter, et al. · Integrative Cancer Therapies · 4
Digital Remote Monitoring Using an mHealth Solution for Survivors of Cancer: Protocol for a Pilot Observational Study
2024 · Pasquale F Innominato, Jamie H Macdonald, et al. · JMIR Research Protocols · 3
A retrospective comparison of frontline platinum in non-squamous non-small-cell lung cancer in North Wales over 9 years
2019 · N. Wreglesworth, M. Chauhan, et al. · Lung Cancer · 1
Drug's Journey of a Thousand Papers Begins With a Single Step
2024 · Pasquale F. Innominato, Nicholas I. Wreglesworth, et al. · JCO Clinical Cancer Informatics
103P Chemotherapy-induced neutropaenia as a marker for overall survival (OS) in non-small cell lung cancer (NSCLC) patients undergoing gemcitabine/carboplatin (GemCarbo) chemotherapy: A 9-year real-life data
2020 · Y.F. Clark, J. Vangara, et al. · Annals of Oncology
A retrospective review of neutrophil-lymphocyte ratio as a predictive prognostic marker in upper gastrointestinal cancers in three UK hospitals over a nine year period
2018 · N. Wreglesworth, C. Roberts, et al. · Annals of Oncology
Implementation of 6 Monthly Bisphosphonate Infusions in Postmenopausal Adjuvant Breast Cancer Patients in a DGH in North Wales
2018 · N. Wreglesworth, C. Bale, et al. · Clinical Oncology
Works count: 15
Citation count: 284
H-index: 7
I10-index: 5
Year
Topic
Type